Shaolin Capital Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Shaolin Capital Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,420	Closed	-$1K	–	700
2022 Q4	$1K	Sell	20,420 -41,222	-67%	-$1.81K	﹤0.01%	781
2022 Q3	$4K	Sell	61,642 -66,930	-52%	-$5.84K	﹤0.01%	904
2022 Q2	$12K	Hold	128,572	–	–	﹤0.01%	901
2022 Q1	$33K	Hold	128,572	–	–	﹤0.01%	834
2021 Q4	$189K	Sell	128,572 -76,689	-37%	-$107K	﹤0.01%	587
2021 Q3	$304K	Buy	205,261 +5,796	+3%	+$6.2K	0.01%	412
2021 Q2	$229K	Buy	199,465 +24,566	+14%	+$23.3K	0.01%	445
2021 Q1	$143K	Buy	+174,899	New	+$256K	0.01%	462

Other funds holding JSPRW

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Shaolin Capital Management's JSPRW Position: Q1 2023 in Review

Shaolin Capital Management sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2023, closing a stake of 20,420 shares — an estimated $1K sold.

Shaolin Capital Management first reported a position in JSPRW in Q1 2021 and held it in 8 quarters. The position peaked at $304K in Q3 2021. 10 funds tracked by Wall St. Rank hold JSPRW as of Q1 2023.

Shaolin Capital Management reported no remaining Japer Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
Shaolin Capital Management sold 20,420 Japer Therapeutics Warrants shares in Q1 2023, an estimated $1K.
Shaolin Capital Management first reported a position in Japer Therapeutics Warrants in Q1 2021 and held it in 8 quarters.
Shaolin Capital Management's Japer Therapeutics Warrants position peaked at $304K in Q3 2021.
10 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2023.

Based on Shaolin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.